Source: Biomedicine & pharmacotherapy. Unidade: FM
Subjects: FÁRMACOS, LEISHMANIOSE VISCERAL, MACRÓFAGOS
ABNT
BORBOREMA, Samanta Etel Treiger et al. Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: a candidate formulation for visceral leishmaniasis. Biomedicine & pharmacotherapy, v. 103, p. 1609-1616, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.biopha.2018.05.004. Acesso em: 18 nov. 2024.APA
Borborema, S. E. T., Osso Junior, J. A., Tempone, A. G., Andrade Junior, H. F. de, & Nascimento, N. do. (2018). Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: a candidate formulation for visceral leishmaniasis. Biomedicine & pharmacotherapy, 103, 1609-1616. doi:10.1016/j.biopha.2018.05.004NLM
Borborema SET, Osso Junior JA, Tempone AG, Andrade Junior HF de, Nascimento N do. Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: a candidate formulation for visceral leishmaniasis [Internet]. Biomedicine & pharmacotherapy. 2018 ; 103 1609-1616.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.biopha.2018.05.004Vancouver
Borborema SET, Osso Junior JA, Tempone AG, Andrade Junior HF de, Nascimento N do. Pharmacokinetic of meglumine antimoniate encapsulated in phosphatidylserine-liposomes in mice model: a candidate formulation for visceral leishmaniasis [Internet]. Biomedicine & pharmacotherapy. 2018 ; 103 1609-1616.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.biopha.2018.05.004